128 related articles for article (PubMed ID: 16566360)
21. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device.
Stenvall H; Wikström I; Backlund I; Wilander E
Acta Obstet Gynecol Scand; 2007; 86(1):16-21. PubMed ID: 17230283
[TBL] [Abstract][Full Text] [Related]
22. Cervical screening.
Rogers N
Aust Fam Physician; 2007 May; 36(5):296. PubMed ID: 17542069
[No Abstract] [Full Text] [Related]
23. [Knowledge of women and men about breast cancer prevention].
Najdyhor E; Krajewska-Kułak E; Krajewska-Ferishah K
Ginekol Pol; 2013 Feb; 84(2):116-25. PubMed ID: 23668058
[TBL] [Abstract][Full Text] [Related]
24. [Comparative analysis of abnormal Pap smear and the results of histopathological examination of specimens from the cervix of the programme in-depth diagnosis cervical cancer conducted at the of Operational Gynecology Department ICZMP in Lodz].
Kulig B; Łukaszek S; Brucka A; Kałuzyński A; Kamer-Bartosińska A; Szyłło K
Ginekol Pol; 2010 Nov; 81(11):828-33. PubMed ID: 21365898
[TBL] [Abstract][Full Text] [Related]
25. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
[TBL] [Abstract][Full Text] [Related]
26. [Women health behaviours regarding prevention and early detection of precancerous lesions and cervical carcinoma].
Nowicki A; Borowa I; Maruszak M
Ginekol Pol; 2008 Dec; 79(12):840-9. PubMed ID: 19175041
[TBL] [Abstract][Full Text] [Related]
27. The influence of knowledge and perception of the risk of cervical cancer on screening behavior in mainland Chinese women.
Gu C; Chan CW; Twinn S; Choi KC
Psychooncology; 2012 Dec; 21(12):1299-308. PubMed ID: 23208838
[TBL] [Abstract][Full Text] [Related]
28. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
McFarlane-Anderson N; Bazuaye PE; Jackson MD; Smikle M; Fletcher HM
BMC Womens Health; 2008 May; 8():9. PubMed ID: 18513406
[TBL] [Abstract][Full Text] [Related]
29. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
[TBL] [Abstract][Full Text] [Related]
30. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.
Legood R; Gray A; Wolstenholme J; Moss S
BMJ; 2006 Jan; 332(7533):79-85. PubMed ID: 16399769
[TBL] [Abstract][Full Text] [Related]
31. Evidence-based, alternative cervical cancer screening approaches in low-resource settings.
Sherris J; Wittet S; Kleine A; Sellors J; Luciani S; Sankaranarayanan R; Barone MA
Int Perspect Sex Reprod Health; 2009 Sep; 35(3):147-54. PubMed ID: 19805020
[No Abstract] [Full Text] [Related]
32. Health education to increase screening for cervical cancer among Lumbee Indian women in North Carolina.
Dignan MB; Michielutte R; Wells HB; Sharp P; Blinson K; Case LD; Bell R; Konen J; Davis S; McQuellon RP
Health Educ Res; 1998 Dec; 13(4):545-56. PubMed ID: 10345905
[TBL] [Abstract][Full Text] [Related]
33. [The results of screening program for cervical cancer in Lodz].
Gottwald L; Giernat L; Lech W; Wójcik-Krowiranda K; Akoel KM; Kowalczyk-Amico K; Estemberg D; Grzesiak M; Sosnowski D; Guzowski G; Baś E; Tyliński W; Bieńkiewicz A
Ginekol Pol; 2002 Nov; 73(11):934-8. PubMed ID: 12722377
[TBL] [Abstract][Full Text] [Related]
34. [Verification of doubtful PAP smear results of women included in the screening program in the Podlaskie province].
Błońska E; Knapp PA
Ginekol Pol; 2013 Aug; 84(8):691-5. PubMed ID: 24191502
[TBL] [Abstract][Full Text] [Related]
35. [Following-up females having an abnormal Pap smear in Colombia].
Wiesner C; Cendales R; Murillo R; Piñeros M; Tovar S
Rev Salud Publica (Bogota); 2010 Feb; 12(1):1-13. PubMed ID: 20628695
[TBL] [Abstract][Full Text] [Related]
36. [Guidelines for application of molecular tests identyfying HR HPV DNA in the prevention of cervical cancer. Statement of experts from PGS (PTG) and NCLD (KIDL)].
;
Ginekol Pol; 2013 May; 84(5):395-9. PubMed ID: 23819408
[TBL] [Abstract][Full Text] [Related]
37. [Widely available cytological examinations and detectability of cervical dysplasia and carcinoma].
Rózewicki S; Słomińska E; Choromański F; Niedzielski A
Ginekol Pol; 1989; 60(7-9):410-4. PubMed ID: 2702200
[TBL] [Abstract][Full Text] [Related]
38. Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya.
Were E; Nyaberi Z; Buziba N
Afr Health Sci; 2011 Mar; 11(1):58-64. PubMed ID: 21572858
[TBL] [Abstract][Full Text] [Related]
39. Cervical Cancer Screening of Adolescents and Young Women: Further Evidence Shows a Lack of Clinical Value.
Campaner AB; Fernandes GL
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):6-11. PubMed ID: 33130243
[TBL] [Abstract][Full Text] [Related]
40. Women at risk: papanicolaou smear screening in Florida.
Vincent AL; Greene JN; Hoercherl S; McTague D
J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
